Heart skipping a beat? Google and Apple want to know — but does your doctor?

Millions of people are gaining access to alerts that flag when their hearts might have skipped a beat; cardiologists are wondering what to do with all that information.

Smart watch

Some cardiologists say the information the devices produce isn’t always useful.

Photo: Luke Chesser/Unsplash

Darius Tahir is a correspondent for Kaiser Health News.If someone’s heart skips a beat, tech companies want to let them know.

Gadget firms — starting with Apple and now Fitbit, which is owned by Google — are selling wearable devices that check heartbeat rhythms and alert users when something is out of sync.

These products involve some feats of technology. Many use sophisticated optical sensors that peer beneath the skin to monitor how blood volume changes — almost like tracking the tides — and thereby tally heartbeats. Other devices have a miniature electrocardiogram — which records the heart’s electrical activity — embedded. Either method can detect irregular heartbeats and potentially atrial fibrillation, a condition that affects an estimated 2.7 million Americans and drives up the risk of stroke and heart failure. When a person has atrial fibrillation, the beating in the heart’s upper chambers is erratic, and blood doesn’t flow as well as it should to the heart’s lower chambers.

Although the gadgets are a technical achievement, some cardiologists say the information the devices produce isn’t always useful. Notifications from the devices aren’t definitive diagnoses.

It’s a conundrum, and a consequential one, for the health care system. Tens of millions of people are armed with these devices, and if even a small fraction of those get a ping, it could mean increased care and costs.

“The technology has outpaced us,” said Rod Passman, a cardiologist at Northwestern University who’s assisting with a study examining the Apple Watch’s ability to screen for the heart rhythm condition. “Industry came out with these things because they could. Now we’re playing catch-up and trying to figure out what to do with this information.”

Heart rhythm sensors are among many tools packed into these wearables. Users can have their steps counted, their sleep tracked and their gait analyzed. Some products will call 911 if the wearer has been in a car crash or had a bad fall.

Those features are meant to make patients the protagonists in maintaining their health. During an event touting Fitbit’s atrial fibrillation function, company co-founder James Park said it was one of several features of the brand’s fitness-tracking bands that are “making users effortlessly in control of health and wellness.”

The wearable’s atrial fibrillation ping — a “test [doctors] didn’t order,” Passman said — tells patients there’s something potentially irregular. Ultimately, though, any treatment is left to the doctor.

The initial visits don’t always provide quick answers. To corroborate a notification, a cardiologist outfits patients with medical-grade diagnostics — a patch or bulky monitor — that are more accurate than wearables. (The Apple Watch, for example, is cleared by the FDA for “informational use only.”) That fancier device may have to operate for a while to catch a momentary missed beat. That waiting means more time and money, spent on more visits to the doctor.

Getting a diagnosis “can be quite the odyssey,” said Ethan Weiss, a cardiologist at the University of California, San Francisco. Patients can become anxious along the way. Social media forums like Reddit show that many users wonder whether their watches or their doctors are more reliable. “It is still freaking me out,” one user wrote, even after a doctor told him he was likely fine.

“There’s going to be a period of uncertainty,” acknowledged Tony Faranesh, a research scientist at Fitbit. He said the company provides educational material to users warned of a potential arrhythmia.

Studies about the prevalence of anxiety that results from atrial fibrillation pings are hard to come by. Fitbit collected such information, Faranesh told KHN, as part of a survey submitted to the FDA for clearance of its device. But the full results of the study — which collected information from 455,000 patients — aren’t yet available.

Diagnosis isn’t the same as knowing what the best treatment should be. For example, treating otherwise healthy patients with anticoagulants — the standard treatment for atrial fibrillation — may expose them to unnecessary side effects.

According to doctors interviewed by KHN, atrial fibrillation is a broad condition. Some patients have many bouts in a given year and symptoms like fatigue or shortness of breath. Some patients don’t notice a thing.

In the past, fleeting fibrillation wouldn’t have been detected, let alone treated. And wearable technology users are healthier and wealthier than the typical atrial fibrillation patient. A new Apple Watch costs around $400; the cheapest Fitbit is around $80. (Company officials couldn’t say which Fitbit devices would have the atrial fibrillation detection function, although they said they were committed to making the tech widely available.)

The combination of a low burden from the health condition and healthier patients means cardiologists aren’t entirely sure what to do with this cohort of patients.

Between the anxiety and the unknowns, the tech companies have nonetheless started the health system on a massive science experiment.

Huge swaths of people have embraced wearable gadgets. Analysts at Counterpoint Research said the Apple Watch — which has included the atrial fibrillation-scanning feature since 2018 — crossed 100 million users worldwide last summer. Fitbit likely has tens of millions more users. How many of them will have the new feature once it’s available isn’t yet clear.

More companies are coming. “Everyone wants to add higher- and higher-caliber medical-grade sensors” to their consumer gadgets, said Justin Klein, managing partner of Vensana Capital, a venture capital firm. It’s “going to drive patients to clinics to get these diagnoses confirmed,” Klein said.

Companies are broadening the capabilities of the wearables even further. Klein said Big Tech and startups alike are eyeing more conditions for gadgets to passively alert users about, from blood oxygen levels to high blood pressure.

Figuring out what to do with these new doodads is up to patients and doctors.

Northwestern’s Passman considers himself an optimist when it comes to the potential of the devices. In an interview — sporting an Apple Watch on his wrist — he said the devices can help doctors and patients manage conditions and respond quickly when there’s a funny flutter. And doctors can use the devices to confirm whether their treatments for atrial fibrillation are working, cardiologists like Passman say.

Still, the feature is likely to lead to headaches for cardiologists. “It’s caused some increased burden, handling phone calls, office visits,” Weiss said — and all for an as-yet-unclear benefit.

KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs atKFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.


Judge Zia Faruqui is trying to teach you crypto, one ‘SNL’ reference at a time

His decisions on major cryptocurrency cases have quoted "The Big Lebowski," "SNL," and "Dr. Strangelove." That’s because he wants you — yes, you — to read them.

The ways Zia Faruqui (right) has weighed on cases that have come before him can give lawyers clues as to what legal frameworks will pass muster.

Photo: Carolyn Van Houten/The Washington Post via Getty Images

“Cryptocurrency and related software analytics tools are ‘The wave of the future, Dude. One hundred percent electronic.’”

That’s not a quote from "The Big Lebowski" — at least, not directly. It’s a quote from a Washington, D.C., district court memorandum opinion on the role cryptocurrency analytics tools can play in government investigations. The author is Magistrate Judge Zia Faruqui.

Keep ReadingShow less
Veronica Irwin

Veronica Irwin (@vronirwin) is a San Francisco-based reporter at Protocol covering fintech. Previously she was at the San Francisco Examiner, covering tech from a hyper-local angle. Before that, her byline was featured in SF Weekly, The Nation, Techworker, Ms. Magazine and The Frisc.

The financial technology transformation is driving competition, creating consumer choice, and shaping the future of finance. Hear from seven fintech leaders who are reshaping the future of finance, and join the inaugural Financial Technology Association Fintech Summit to learn more.

Keep ReadingShow less
The Financial Technology Association (FTA) represents industry leaders shaping the future of finance. We champion the power of technology-centered financial services and advocate for the modernization of financial regulation to support inclusion and responsible innovation.

AWS CEO: The cloud isn’t just about technology

As AWS preps for its annual re:Invent conference, Adam Selipsky talks product strategy, support for hybrid environments, and the value of the cloud in uncertain economic times.

Photo: Noah Berger/Getty Images for Amazon Web Services

AWS is gearing up for re:Invent, its annual cloud computing conference where announcements this year are expected to focus on its end-to-end data strategy and delivering new industry-specific services.

It will be the second re:Invent with CEO Adam Selipsky as leader of the industry’s largest cloud provider after his return last year to AWS from data visualization company Tableau Software.

Keep ReadingShow less
Donna Goodison

Donna Goodison (@dgoodison) is Protocol's senior reporter focusing on enterprise infrastructure technology, from the 'Big 3' cloud computing providers to data centers. She previously covered the public cloud at CRN after 15 years as a business reporter for the Boston Herald. Based in Massachusetts, she also has worked as a Boston Globe freelancer, business reporter at the Boston Business Journal and real estate reporter at Banker & Tradesman after toiling at weekly newspapers.

Image: Protocol

We launched Protocol in February 2020 to cover the evolving power center of tech. It is with deep sadness that just under three years later, we are winding down the publication.

As of today, we will not publish any more stories. All of our newsletters, apart from our flagship, Source Code, will no longer be sent. Source Code will be published and sent for the next few weeks, but it will also close down in December.

Keep ReadingShow less
Bennett Richardson

Bennett Richardson ( @bennettrich) is the president of Protocol. Prior to joining Protocol in 2019, Bennett was executive director of global strategic partnerships at POLITICO, where he led strategic growth efforts including POLITICO's European expansion in Brussels and POLITICO's creative agency POLITICO Focus during his six years with the company. Prior to POLITICO, Bennett was co-founder and CMO of Hinge, the mobile dating company recently acquired by Match Group. Bennett began his career in digital and social brand marketing working with major brands across tech, energy, and health care at leading marketing and communications agencies including Edelman and GMMB. Bennett is originally from Portland, Maine, and received his bachelor's degree from Colgate University.


Why large enterprises struggle to find suitable platforms for MLops

As companies expand their use of AI beyond running just a few machine learning models, and as larger enterprises go from deploying hundreds of models to thousands and even millions of models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

As companies expand their use of AI beyond running just a few machine learning models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

Photo: artpartner-images via Getty Images

On any given day, Lily AI runs hundreds of machine learning models using computer vision and natural language processing that are customized for its retail and ecommerce clients to make website product recommendations, forecast demand, and plan merchandising. But this spring when the company was in the market for a machine learning operations platform to manage its expanding model roster, it wasn’t easy to find a suitable off-the-shelf system that could handle such a large number of models in deployment while also meeting other criteria.

Some MLops platforms are not well-suited for maintaining even more than 10 machine learning models when it comes to keeping track of data, navigating their user interfaces, or reporting capabilities, Matthew Nokleby, machine learning manager for Lily AI’s product intelligence team, told Protocol earlier this year. “The duct tape starts to show,” he said.

Keep ReadingShow less
Kate Kaye

Kate Kaye is an award-winning multimedia reporter digging deep and telling print, digital and audio stories. She covers AI and data for Protocol. Her reporting on AI and tech ethics issues has been published in OneZero, Fast Company, MIT Technology Review, CityLab, Ad Age and Digiday and heard on NPR. Kate is the creator of RedTailMedia.org and is the author of "Campaign '08: A Turning Point for Digital Media," a book about how the 2008 presidential campaigns used digital media and data.

Latest Stories